pioglitazone hydrochloride and metformin hydrochloride
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (pioglitazone hydrochloride and metformin hydrochloride) by Aurobindo Pharma is agents: pioglitazone and metformin. Approved for type 2 diabetes mellitus, type 1 diabetes mellitus. First approved in 2013.
Drug data last refreshed 23h ago
agents: pioglitazone and metformin. Pioglitazone Pioglitazone is a thiazolidinedione that depends on the presence of insulin for its mechanism of action. Pioglitazone decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and…
Worked on PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease